We are live on
!
Find out more
TM
Taproot Management Portfolio holdings
AUM
$530M
This Fund
S&P 500
This Quarter
Est. Return
+0.75%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$530M
AUM Growth
-$87.6M
(-14%)
Cap. Flow
-$76.4M
Cap. Flow
% of AUM
-14.42%
Top 10 Holdings %
Top 10 Hldgs %
16.44%
Holding
243
New
96
Increased
35
Reduced
49
Closed
63
Avg Time Held
0.5
quarters
Top 10 Avg Time Held
0.3
quarters
Top 20 Avg Time Held
0.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AVB
AvalonBay Communities
AVB
|
+$8.86M |
| 2 |
AbbVie
ABBV
|
+$8M |
| 3 |
Abbott
ABT
|
+$7.95M |
| 4 |
Coca-Cola
KO
|
+$7.75M |
| 5 |
Elevance Health
ELV
|
+$7.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$11.3M |
| 2 |
Sanofi
SNY
|
+$10.2M |
| 3 |
Medtronic
MDT
|
+$10.2M |
| 4 |
Factset
FDS
|
+$9.91M |
| 5 |
GE Vernova
GEV
|
+$9.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.6% |
| 2 | Industrials | 20.75% |
| 3 | Consumer Discretionary | 16.07% |
| 4 | Consumer Staples | 12.4% |
| 5 | Real Estate | 11.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Performance Food Group
PFGC
$14.9B
| $11M | 2.07% |
127,841
-10,474
| -8% | -$958K |
2025 Q4
1 quarter
|
|
2
West Pharmaceutical
WST
$25.8B
| $10.9M | 2.07% |
43,673
-1,085
| -2% | -$270K |
2025 Q4
1 quarter
|
|
|
3
Elevance Health
ELV
$89.5B
| $9.4M | 1.77% |
32,111
+22,731
| +242% | +$7.47M |
2025 Q4
1 quarter
|
|
4
Thermo Fisher Scientific
TMO
$243B
| $9.37M | 1.77% |
19,058
-640
| -3% | -$347K |
2025 Q4
1 quarter
|
|
|
AVB
5
DELISTED
AvalonBay Communities
AVB
| $8.68M | 1.64% |
53,155
+50,699
| +2,064% | +$8.86M |
2025 Q4
1 quarter
|
|
|
6
AbbVie
ABBV
$489B
| $7.85M | 1.48% |
+36,080
| New | +$8M |
2026 Q1
0 quarters
|
|
|
7
Coca-Cola
KO
$379B
| $7.8M | 1.47% |
+102,508
| New | +$7.75M |
2026 Q1
0 quarters
|
|
8
Fastenal
FAST
$58.2B
| $7.5M | 1.42% |
161,700
+125,404
| +346% | +$5.63M |
2025 Q4
1 quarter
|
|
9
Regal Rexnord
RRX
$11B
| $7.37M | 1.39% |
+39,360
| New | +$7.32M |
2026 Q1
0 quarters
|
|
|
10
Abbott
ABT
$172B
| $7.23M | 1.37% |
+70,425
| New | +$7.95M |
2026 Q1
0 quarters
|
|
11
ITT
ITT
$18B
| $7.12M | 1.34% |
37,381
-33,934
| -48% | -$6.46M |
2025 Q4
1 quarter
|
|
12
American Homes 4 Rent
AMH
$11.1B
| $6.79M | 1.28% |
243,202
+40,270
| +20% | +$1.22M |
2025 Q4
1 quarter
|
|
13
CVS Health
CVS
$110B
| $6.68M | 1.26% |
93,028
-64,434
| -41% | -$4.96M |
2025 Q4
1 quarter
|
|
14
CubeSmart
CUBE
$8.55B
| $6.49M | 1.23% |
177,151
-47,420
| -21% | -$1.82M |
2025 Q4
1 quarter
|
|
15
Clorox
CLX
$10.1B
| $6.22M | 1.17% |
+60,011
| New | +$6.8M |
2026 Q1
0 quarters
|
|
16
Royalty Pharma
RPRX
$25.3B
| $6.22M | 1.17% |
129,592
-155,095
| -54% | -$6.79M |
2025 Q4
1 quarter
|
|
17
Ollie's Bargain Outlet
OLLI
$5.07B
| $6.21M | 1.17% |
67,520
+50,224
| +290% | +$5.42M |
2025 Q4
1 quarter
|
|
18
Ferguson
FERG
$42.6B
| $6.09M | 1.15% |
26,108
+14,706
| +129% | +$3.58M |
2025 Q4
1 quarter
|
|
19
Church & Dwight Co
CHD
$23.3B
| $5.77M | 1.09% |
+61,791
| New | +$5.94M |
2026 Q1
0 quarters
|
|
20
Brinker International
EAT
$8.12B
| $5.7M | 1.08% |
+39,934
| New | +$6.08M |
2026 Q1
0 quarters
|
|
21
Mettler-Toledo International
MTD
$31.1B
| $5.66M | 1.07% |
4,485
-3,413
| -43% | -$4.6M |
2025 Q4
1 quarter
|
|
22
Constellation Brands
STZ
$20.8B
| $5.63M | 1.06% |
37,544
-10,237
| -21% | -$1.58M |
2025 Q4
1 quarter
|
|
23
ASML
ASML
$684B
| $5.44M | 1.03% |
4,117
+3,214
| +356% | +$4.4M |
2025 Q4
1 quarter
|
|
24
Pfizer
PFE
$161B
| $5.42M | 1.02% |
+192,873
| New | +$5.13M |
2026 Q1
0 quarters
|
|
25
IDEX
IEX
$17.3B
| $5.38M | 1.02% |
+28,398
| New | +$5.61M |
2026 Q1
0 quarters
|
|
Similar funds
FGAM
BFIC
AIM
OCM
JHCP
OWM
DCM
FFWA
Taproot Management's Q1 2026 Portfolio in Review
As of Q1 2026, Taproot Management held 243 positions worth $530M, down 14% from $617M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Taproot Management withdrew a net $76.4M in Q1 2026, closing 63 positions and reducing 49 holdings. Its most notable exit was Boston Scientific, an estimated $11.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 31% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Taproot Management opened a new position in AbbVie worth $7.85M.
- Taproot Management's largest Q1 2026 buy was AbbVie: 36,080 shares worth $7.85M.
- Taproot Management added most to AvalonBay Communities in Q1 2026, an estimated $8.86M increase.
- Taproot Management's biggest Q1 2026 reduction was Jabil, cutting an estimated $9.26M.
- Taproot Management fully exited Boston Scientific in Q1 2026, selling an estimated $11.3M.
- Taproot Management's ten largest holdings make up 16% of its $530M portfolio in Q1 2026.
- Taproot Management opened 96 new positions and closed 63 in Q1 2026.
- Taproot Management's portfolio value fell 14% quarter-over-quarter to $530M.
Based on Taproot Management's 13F filing for Q1 2026, filed 13 May 2026.